0
Menu
Upload Prescription

Tab. ELAGOX 200mg

Thumbnail
Tab. ELAGOX 200mg
Painkiller

1 strip = 10

Nuvista Pharma Ltd
Generic Name: Elagolix Sodium
MRP ৳ 2200 9% Off
Best Price ৳ 2000
Order Now
Product Description

Indication

Moderate to severe pain associated with endometriosis.

Pharmacology (Mechanism of Action)

GnRH receptor antagonist.

Blocks GnRH receptors in the pituitary gland → ↓ LH & FSH secretion → ↓ estradiol and progesterone levels.

Dosage & Administration

Before starting: Exclude pregnancy and start within 7 days of onset of menses.

150 mg once daily: Up to 24 months (moderate hepatic impairment: up to 6 months).

200 mg twice daily: Up to 6 months (especially with dyspareunia).

Not recommended: 200 mg in moderate to severe hepatic impairment.

<18 years: Safety and efficacy not established.

Drug Interactions

Increases effects of P-gp substrates (e.g., digoxin).

Increases effects of CYP2C19 substrates (e.g., omeprazole; max 40 mg/day).

May reduce effects of CYP3A substrates.

May reduce effectiveness of estrogen-containing contraceptives.

No significant food interaction.

Contraindications

Pregnancy.

Osteoporosis.

Severe hepatic impairment.

Concomitant use with strong OATP1B1 inhibitors (e.g., cyclosporine, gemfibrozil).

Side Effects


Common:


Hot flushes

Night sweats

Headache

Nausea

Amenorrhea

Arthralgia

Mood changes

Bone loss (↓ BMD)


Rare:


Insomnia

Anxiety

Elevated liver enzymes (ALT)

Pregnancy & Lactation

Contraindicated in pregnancy (may increase risk of early pregnancy loss).

Discontinue immediately if pregnancy occurs.

Safety during breastfeeding is unknown.

Precautions & Warnings

May cause bone mineral density (BMD) loss (dose & duration dependent).

Can alter menstrual bleeding, making pregnancy difficult to recognize.

Monitor for depression, anxiety, suicidal thoughts.

Monitor liver function (ALT).

Use non-hormonal contraception during treatment and for 1 week after stopping.

Special Populations

No dose adjustment in renal impairment (including dialysis).

No dose adjustment in mild hepatic impairment.

Not established in patients <18 years.

Overdose

Symptomatic and supportive treatment; monitor for adverse effects.

Therapeutic Class

Gonadotropin-Releasing Hormone (GnRH) antagonist

Storage

Store in a cool, dry place, protected from light and moisture.

Keep out of reach of children.

Cart

Your cart is empty